These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27746428)

  • 1. Major Increases between Pre- and Post-breakfast Glucose Levels May Predict Nocturnal Hypoglycemia in Type 2 Diabetes.
    Takeishi S; Mori A; Kawai M; Yoshida Y; Hachiya H; Yumura T; Ito S; Shibuya T; Fushimi N; Ohashi N; Kawai H
    Intern Med; 2016; 55(20):2933-2938. PubMed ID: 27746428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Relationship between Morning Glycemic Variability and Patient Characteristics Using Continuous Glucose Monitoring Data in Patients with Type 2 Diabetes.
    Takeishi S; Mori A; Kawai M; Yoshida Y; Hachiya H; Yumura T; Ito S; Shibuya T; Fushimi N; Ohashi N; Kawai H
    Intern Med; 2017; 56(12):1467-1473. PubMed ID: 28626170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
    Mitsuishi S; Nishimura R; Ando K; Tsujino D; Utsunomiya K
    PLoS One; 2015; 10(12):e0144041. PubMed ID: 26625003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.
    Takahashi H; Nishimura R; Onda Y; Ando K; Tsujino D; Utsunomiya K
    PLoS One; 2017; 12(7):e0177283. PubMed ID: 28683068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it possible to predict the onset of nocturnal asymptomatic hypoglycemia in patients with type 1 diabetes receiving insulin degludec? Potential role of previous day and next morning glucose values.
    Takahashi H; Nishimura R
    J Diabetes Investig; 2021 Mar; 12(3):365-373. PubMed ID: 32671977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia.
    Baretić M; Bralić Lang V
    BMC Endocr Disord; 2020 Mar; 20(1):35. PubMed ID: 32151247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
    Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
    Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
    Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
    Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.
    Takeishi S; Tsuboi H; Takekoshi S
    J Diabetes Investig; 2018 Jan; 9(1):91-99. PubMed ID: 28371461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Continuous Glucose Monitoring Can Predict Severe Hypoglycemia in People with Type 1 Diabetes: Combined Analysis of the HypoDE and DIAMOND Trials.
    Hermanns N; Ehrmann D; Heinemann L; Freckmann G; Waldenmaier D; Calhoun P
    Diabetes Technol Ther; 2022 Sep; 24(9):603-610. PubMed ID: 35604794
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal Coefficient of Variance Threshold to Minimize Hypoglycemia Risk in Individuals with Well-Controlled Type 1 Diabetes Mellitus.
    Yoo JH; Yang SH; Jin SM; Kim JH
    Diabetes Metab J; 2024 May; 48(3):429-439. PubMed ID: 38476023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement.
    Rossi MC; Lucisano G; Ceriello A; Mazzucchelli C; Musacchio N; Ozzello A; Nicolucci A; Di Bartolo P;
    Acta Diabetol; 2018 Oct; 55(10):1059-1066. PubMed ID: 30062588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring.
    Bergenstal RM; Strock E; Mazze R; Powers MA; Monk AM; Richter S; Souhami E; Ahrén B
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus.
    Porter PA; Keating B; Byrne G; Jones TW
    J Pediatr; 1997 Mar; 130(3):366-72. PubMed ID: 9063410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
    Wang X; Ioacara S; DeHennis A
    Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.